@article{da19bd8cdd40458585247468f5ddb7da,
title = "Five-year outcomes of the Partial oral Treatment of endocarditis (POET) trial",
keywords = "Administration, Intravenous, Administration, Oral, Anti-Bacterial Agents/administration & dosage, Endocarditis, Bacterial/drug therapy, Follow-Up Studies, Humans, Treatment Outcome",
author = "Pries-Heje, {Mia M.} and Christoffer Wiingaard and Nikolaj Ihlemann and Gill, {Sabine U.} and Bruun, {Niels E.} and Hanne Elming and Povlsen, {Jonas A.} and Trine Madsen and Jensen, {Kaare T.} and Kurt Fursted and Martin Schultz and Lauge {\O}stergaard and Christensen, {Jens J.} and Ulrik Christiansen and Flemming Rosenvinge and Jannik Helweg-Larsen and Fosb{\o}l, {Emil L.} and Lars K{\o}ber and Christian Torp-Pedersen and Niels T{\o}nder and Claus Moser and Kasper Iversen and Henning Bundgaard",
note = "Funding Information: Supported by grants from the Danish Heart Foundation , the Svend Andersens Foundation , the Capital Regions Research Council , the Hartmann{\textquoteright}s Foundation , and the Novo Nordisk Foundation . ",
year = "2022",
month = feb,
day = "10",
doi = "10.1056/NEJMc2114046",
language = "English",
volume = "386",
pages = "601--602",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "6",
}